HomeFNCH • NASDAQ
add
Finch Therapeutics Group Inc
Previous close
$2.10
Day range
$1.92 - $2.07
Year range
$1.86 - $16.74
Market cap
3.08M USD
Avg Volume
84.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.16M | -46.30% |
Net income | -3.88M | 93.78% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.12M | 66.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 20.76M | -50.19% |
Total assets | 50.09M | -36.62% |
Total liabilities | 31.05M | -32.62% |
Total equity | 19.04M | — |
Shares outstanding | 1.61M | — |
Price to book | 0.18 | — |
Return on assets | -24.48% | — |
Return on capital | -25.41% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.88M | 93.78% |
Cash from operations | -4.36M | 67.40% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.36M | 85.24% |
Free cash flow | -3.74M | 48.49% |
About
Founded
2014
Headquarters
Website
Employees
1